Remote patient monitoring can help enhance chronic care management in many ways, including allowing clinicians to track their patients daily and adjust treatment plans in real time. May 27, 2022 – Amid the rapid expansion of virtual care, remote patient monitoring (RPM) has emerged as a reliable tool for treating both acute and chronic conditions. RPM involves […]
The most powerful drivers for digital home hospital adoption are advances in telehealth, remote monitoring and emerging digital technologies that facilitate high quality, cost-effective care beyond hospital walls. By GARY MANNING May 4, 2022 at 4:19 PM In 2005, a study in the Annals of Internal Medicine demonstrated that digital home hospital, or hospital-at-home, solutions delivered better clinical outcomes, […]
Remote patient monitoring (RPM) provides clear benefits for clinicians, health systems and patients. Patients can stay at home, and go about their daily routines, while their conditions are monitored, reassured in the knowledge that action can be taken if needed. Meanwhile, health providers can plan resources knowing which ongoing patient conditions can be managed remotely, […]
Program Will Support Connected Care Services Across Country, Focus on Low-Income and Veteran Patients — WASHINGTON, March 16, 2022—Today, the Federal Communications Commission announced its fourth and final set of approved Connected Care Pilot Program projects. These 16 projects were approved for a total of $29,752,601 in funding. With the newly selected projects, the […]
ASX ANNOUNCEMENT23 December 2021 Respiri enters its first 5 year Remote Patient Monitoring (RPM) Distribution/Marketing Agreement in the United States with mTelehealth, LLCHighlights:• Five-year, Non-Exclusive Distribution and Marketing Agreement signed with mTelehealth in the key USmarket• mTelehealth is a premier provider of RPM services based in Florida• First key distribution and marketing agreement signed in […]
The e-health company’s shares closed in the green today on news of a new partnership Published December 23, 4:39pm AEDT The Respiri Ltd (ASX: RSH) share price leapt 14% to 6.5 cents in early trading this morning. This came following the announcement of a distribution and marketing deal with a United States healthcare company. At the closing bell, Respiri shares had […]
Markets Reporter jessica.defreitas@themarketherald.com.au 23 December 2021 14:54 (AEDT) Respiri (RSH) signs a five-year non-exclusive distribution and marketing deal with US-based remote patient monitoring (RPM) and chronic care provider, mTelehealth mTelehealth will initially order US$150,000 (A$208,087) worth of wheezo devices and services but the deal is expected to generate US$1 million (A$1.4 million) in sales Respiri believes […]
The study aimed to identify the usefulness of telemonitoring to detect and manage acute exacerbation of COPD (AECOPD). Telemonitoring can reduce emergency department (ED) visits and exacerbation-related readmissions, as well as acute exacerbation-related hospital days in chronic obstructive pulmonary disease (COPD), according to a recent analysis out of China. The results also showed improvements in mortality […]
September 28, 2021 – All those with Chronic Obstructive Pulmonary Disease (COPD) now can have access to the RESPIPLUS™ Living Well with COPD self-care resources through the Aetonix aTouchAway® digital platform. More than 2 million Canadians aged 35 and older are living with COPD, a debilitating condition that impacts every element of life for its […]
Respiri (RSH) has received United States Food and Drug Administration (FDA) clearance for its wheezing aid, Wheezo Wheezo monitors wheezing to manage and improve asthma With the green tick from the FDA, the company can now market and sell the technology in the United States On the market this afternoon, Respiri is in the grey […]